IVRS and the NIAC Consortium Receive a Prestigious Eurostars Grant for Drug Development on Renal Cell Carcinoma
Exciting news! IVRS AB is proud to be a key partner in the NIAC consortium, recently awarded a €1.36M Eurostars grant for groundbreaking renal cell carcinoma (RCC) research! We’ll be leveraging our cutting-edge in vivo RCC models and whole-body 3D imaging to evaluate a novel inhibitor developed by AtG Therapeutics. This promising therapeutic could offer new hope for […]